4//SEC Filing
Jandrich Steven 4
Accession 0001104659-23-058642
CIK 0001609550other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 8:17 PM ET
Size
10.4 KB
Accession
0001104659-23-058642
Insider Transaction Report
Form 4
Jandrich Steven
Chief Comp Off & VP, Human Res
Transactions
- Exercise/Conversion
Common Stock
2023-05-08$42.15/sh+1,727$72,793→ 6,098 total - Sale
Common Stock
2023-05-08$280.12/sh−1,727$483,767→ 4,371 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-05-08−1,727→ 3,705 totalExercise: $42.15Exp: 2028-12-18→ Common Stock (1,727 underlying)
Holdings
- 478(indirect: By daughter)
Common Stock
- 478(indirect: By son)
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2022 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Documents
Issuer
Inspire Medical Systems, Inc.
CIK 0001609550
Entity typeother
Related Parties
1- filerCIK 0001737203
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 8:17 PM ET
- Size
- 10.4 KB